The 2026 revenue guidance was raised to $582 million–$592 million, assuming high single-digit to low double-digit growth for ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with ...
Ormcotm Corporation, a global leader in orthodontic solutions for over 65 years, today announced the expanded capabilities of ...
Co-Diagnostics, Inc. ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release ...
A treatment option for prostate cancer patients is now available in the Midstate. The UPMC Hillman Cancer Center in ...
Gene syntax alters DNA supercoiling to amplify or suppress nearby genes. This could improve the effectiveness of gene ...
Prolific Machines technology gives developers precise, real-time control over when and how much protein a cell produces.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results